Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates

BACKGROUND: Clinically significant portal hypertension (CSPH) has been identified as an important prognostic factor in patients with hepatocellular carcinoma (HCC) undergoing curative treatment. This study aimed to assess PH estimates as prognostic factors in patients with HCC treated with immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Lukas, Gairing, Simon J., Foerster, Friedrich, Weinmann, Arndt, Mittler, Jens, Stoehr, Fabian, Graafen, Dirk, Düber, Christoph, Galle, Peter R., Kloeckner, Roman, Hahn, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127076/
https://www.ncbi.nlm.nih.gov/pubmed/37098584
http://dx.doi.org/10.1186/s40644-023-00558-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127076/
https://www.ncbi.nlm.nih.gov/pubmed/37098584
http://dx.doi.org/10.1186/s40644-023-00558-7

Ejemplares similares